VIP treatment prevents embryo resorption by modulating efferocytosis and activation profile of maternal macrophages in the CBAxDBA resorption prone model

Successful embryo implantation occurs followed by a local pro-inflammatory response subsequently shifted toward a tolerogenic one. VIP (vasoactive intestinal peptide) has embryotrofic, anti-inflammatory and tolerogenic effects. In this sense, we investigated whether the in vivo treatment with VIP co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gallino, L., Calo, G., Hauk, V., Fraccaroli, L., Grasso, E., Vermeulen, M., Leirós, C.P., Ramhorst, R.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_20452322_v6_n_p_Gallino
Aporte de:

Ejemplares similares